Novel Indole-fused benzo-oxazepines (IFBOs) inhibit invasion of hepatocellular carcinoma by targeting IL-6 mediated JAK2/STAT3 oncogenic signals
Open Access
- 12 April 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-13
Abstract
Inspired by the well-documented tumor protecting ability of paullones, recently, we synthesized novel paullone-like scaffolds, indole-fused benzo-oxazepines (IFBOs), and screened them against hepatocellular carcinoma (HCC) specific Hep-G2 cells. Three of the synthesized compounds significantly attenuated the progression of HCCin vitro. By computational studies, we further discovered that IFBOs exhibited a stable binding complex with the IL-6 receptor. In this context, we investigatedin vivostudy using the nitrosodiethyl amine (NDEA)-induced HCC model, which strengthened our previous findings by showing the blockade of the IL-6 mediated JAK2/STAT3 oncogenic signaling pathway. Treatment with IFBOs showed remarkable attenuation of cellular proliferation, as evidenced through a decrease in the number of nodules, restoration of body weight, oxidative stress parameters, liver marker enzymes and histological architecture. Interestingly, using a metabolomic approach we further discovered that IFBOs can restore the perturbed metabolic profile associated with the HCC condition to normalcy. Particularly, the efficacy of compound6afor an anti-HCC response was significantly better than the marketed chemotherapeutic drug, 5-fluorouracil. Altogether, these remarkable findings open up possibilities of developing IFBOs as novel future candidate molecules for plausible alternatives for HCC treatment.Keywords
This publication has 58 references indexed in Scilit:
- Over-expression of COX-2 mRNA in colorectal cancerBMC Gastroenterology, 2014
- ¹H NMR-based metabolic profiling of human rectal cancer tissueMolecular Cancer, 2013
- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue MetabolomicsCancer Research, 2013
- Analysis of colorectal cancers in British Bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of RBFOX1 deletionMolecular Cancer, 2013
- HMDB 3.0—The Human Metabolome Database in 2013Nucleic Acids Research, 2012
- Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cellsJournal of Inorganic Biochemistry, 2012
- Sequential analysis of diethylnitrosamine-induced hepatocarcinogenesis in ratsExperimental and Therapeutic Medicine, 2011
- Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular CarcinogenesisCancer Cell, 2011
- Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancerInternational Journal of Cancer, 2010
- The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancerTrends in Molecular Medicine, 2008